Health Care & Life Sciences » Pharmaceuticals | Sinphar Pharmaceutical Co. Ltd.

Sinphar Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,578
2,642
2,187
2,134
2,134
2,216
Cost of Goods Sold (COGS) incl. D&A
1,678
1,629
1,498
1,473
1,435
1,503
Gross Income
900
1,013
690
661
699
713
SG&A Expense
737
869
808
803
761
832
EBIT
163
144
119
142
62
119
Unusual Expense
9
1
3
3
-
-
Non Operating Income/Expense
248
39
41
106
16
46
Interest Expense
19
20
21
22
21
20
Pretax Income
410
207
59
35
53
88
Income Tax
85
108
25
29
37
35
Consolidated Net Income
325
99
84
64
90
123
Net Income
301
163
14
17
37
9
Net Income After Extraordinaries
301
163
14
17
37
9
Net Income Available to Common
301
163
14
17
37
9
EPS (Basic)
1.79
0.97
0.09
0.10
0.22
0.05
Basic Shares Outstanding
168
168
168
168
168
168
EPS (Diluted)
1.79
0.97
0.08
0.10
0.22
0.05
Diluted Shares Outstanding
168
168
168
168
168
168
EBITDA
331
337
108
117
177
120
Non-Operating Interest Income
10
14
13
8
5
6
Minority Interest Expense
24
64
97
81
127
132

About Sinphar Pharmaceutical Co.

View Profile
Address
84 Chung Shan Road
I-lan 269
Taiwan
Employees -
Website http://www.sinphar.com
Updated 07/08/2019
Sinphar Pharmaceutical Co. Ltd. is engaged in the manufacturing, processing and trading of various western medicines, medicated cosmetics, nutriment and cleaning liquid. Its activities include the manufacturing and selling of healthy products and raw materials. The company's operations are carried out in Taiwan, China, Australia and North America.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.